Why might micafungin be the drug of choice in pediatric patients?;¿por qué micafungina puede ser de elección en el paciente pediátrico?

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 29, Issue SUPPL. 2, 2011, Pages 23-28

  Ramos Amador, José Tomás ^a   Prieto Tato, Luis ^a   Guillén Martín, Sara ^a  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

Author keywords

Children; Micafungin; Premature infants

Indexed keywords

AMINOTRANSFERASE; AMPHOTERICIN B LIPID COMPLEX; ECHINOCANDIN; FLUCONAZOLE; MICAFUNGIN;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; ARTICLE; ASPERGILLUS; BODY WEIGHT; CANDIDA; DRUG CLEARANCE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INVASIVE ASPERGILLOSIS; INVASIVE CANDIDIASIS; LIVER DISEASE; NEUTROPENIA; PREGNANCY; PREMATURITY; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AGE FACTORS; ANIMALS; ANTIFUNGAL AGENTS; BLOOD-BRAIN BARRIER; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; DOUBLE-BLIND METHOD; DRUG APPROVAL; DRUG EVALUATION, PRECLINICAL; ECHINOCANDINS; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; LIPOPEPTIDES; META-ANALYSIS AS TOPIC; MULTICENTER STUDIES AS TOPIC; MYCOSES; RABBITS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 79953183629     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/S0213-005X(11)70005-2     Document Type: Article

References (33)

1. W.J. Steinbach, and T.J. Walsh Mycosis in pediatric patients Infect Dis Clin North Am 20 2006 663 678
2. K.A. Marr, F. Carter, F. Crippa, A. Wald, and L. Corey Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients Clin Infect Dis 34 2002 909 917 (Pubitemid 34229758)
3. L. Sung Invasive fungal infections in children with cancer J Pediatr Suppl 156 2010 S68 S73
4. D.K. Benjamin, B.J. Stoll, A.A. Fanaroff, S.A. McDonald, W. Oh, and R.D. Higgins Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopment outcomes at 18 to 22 months Pediatrics 117 2006 84 92 (Pubitemid 46050523)
5. D.A. Kauffman Neonatal candidiasis: clinical manifestations, management, and prevention strategies J Pediatr 156 Suppl 2010 S53 S67
6. L. Saiman, E. Ludington, M. Pfaller, S. Rangel-Frausto, R.T. Wiblin, and J. Dawson Risk factors for candidemia in neonatal intensive care unit patients. The National Epidemiology of Mycosis Survey study group Pediatr Infect Dis J 19 2000 319 324 (Pubitemid 30213071)
7. Y. Krupova, D. Sejnova, J. Dzatkova, E. Kaiserova, M. Kiskova, and R. Babela Prospective study of fungemia in children with cancer: análisis of 35 cases and comparison with 130 fungemias in adults Support Care Cancer 8 2000 427 432
8. H.L. Vanderbussche, and D.A. Van Loo A clinical review of echinocandins in pediatric patients Ann Pharmacother 44 2010 166 177
9. M.E. Infante, and P. Rojo Utilidad clínica de la micafungina en el tratamiento de la candidiasis invasora en el neonato Rev Iberoam Micol 26 2009 57 61
10. L. Madero López Utilidad clínica de la micafungina en el niño y el adolescente Rev Iberoam Micol 26 2009 62 64
11. T. Lehrnbecher, and A.H. Groll Micafungin: a brief review of pharmacology, safety and antifungal efficacy in pediatric patients Pediatr Blood Cancer 55 2010 229 232
12. I. Vescan, A.K. Ketko, and J. Sobel Spontaneous in vitro resistance to echinocandins among Candida parapsilosis and Candida albicans isolates International Conference for Antimicrobial Agents and Chemotherapy (ICAAC) Chicago 2007 Abstract M-532
13. M.A. Pfaller, L. Boyken, R.J. Hollis, J. Kroeger, S.A. Messer, and S. Tendolkar In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin and micafungin: six years of global surveillance J Clin Microbiol 46 2008 150 156
14. N.J. Carter, and G.M. Keating Micafungin: a review of its use in the prophylaxis and treatment of invasive candidiasis in pediatric patients Paediatr Drugs 11 2009 271 291
15. D. Benjamin, P.B. Smith, A. Arrieta, L. Castro, P.J. Sánchez, and D. Kaufman safety and pharmacokinetics of repeat-dose micafungin in young infants Clin Pharm 87 2010 93 99
16. N. Seibel, C. Schwartz, A. Arrieta, P. Flynn, A. Shad, and E. Albano Safety, tolerability and pharmacokinetics of micafungin (MK 463) in febrile neutropenic pediatric patients Antimicrob Agents Chemother 49 2005 3317 3324 (Pubitemid 41060577)
17. K. Tabata, M. Katashima, A. Kawamura, Y. Tanigawara, and K. Sunagawa Linear pharmacokinetics of micafungin and its active metabolite in Japanese pediatric patients with fungal infection Biol Pharm Bull 29 2006 1706 1711 (Pubitemid 44166376)
18. P.A. Mehta, A.A. Vinks, A. Filipovich, J. Bleesing, S. Jodele, and M.B. Jordan Alternate-day micafunfin prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic study Biol Blood Marrow Transplant 16 2010 1458 1462
19. G.P. Heresi, D.R. Gerstmann, M.D. Reed, J.N. Van den Anker, J.L. Blumer, and L. Kovanda The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants Pediatr Infect Dis J 25 2006 1110 1115 (Pubitemid 44900673)
20. M. Kawada, N. Fukuoka, M. Kondo, K. Okazaki, T. Kusaka, and K. Kawada Pharmacokinetics of prophylactic micafungin in very-low-birth-weight infants Pediatr Infect Dis J 28 2009 840 842
21. P.B. Smith, T.J. Walsh, W. Hope, A. Arrieta, A. Takada, and L.L. Kovanda Pharmacokinetics of an elevated dosage of micafungin in premature neonates Pediatr Infect Dis J 28 2009 412 415
22. W.W. Hope, P.B. Smith, A. Arrieta, D.N. Buell, M. Roy, and A. Kaibara Population pharmacokinetics of micafungin in neonates and young infants Antimicrob Agents Chemother 54 2010 2633 2637
23. O.A. Cornely, P. Maddidon, and AJ. Ullman Pooled analysis of safety for micafungin International Conference for Antimicrobial Agents and Chemotherapy (ICAAC) Chicago 2007 Abstract M-1175
24. J.A. Van Burik, V. Ratanatharathorn, D.E. Stepan, C.B. Miller, J.H. Lipton, and D.H. Vesole Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation Clin Infect Dis 39 2004 1407 1416 (Pubitemid 39518200)
25. S.h. Kusuki, Y. Hashii, H. Yoshida, S.h. Takizawa, E. Sato, and S. Tokimasa Antifungal prophylaxis with micafungin in patients treated for childhood cancer Pediatr Blood Cancer 5 2009 605 609
26. E.R. Kuse, P. Chetchotisakd, C.A. Da Cunha, M. Ruhnke, C. Barrios, and D. Raghunadharao Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial Lancet 369 2007 1519 1527 (Pubitemid 46670281)
27. F. Queiroz-Telles, E. Berezin, G. Leverger, A. Freire, A. Van der Vyer, and T. Chotpitayasunondh Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis Pediatr Infect Dis J 27 2008 820 827
28. ®) in paediatric patients with invasive candidiasis or candidaemia 17th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) Munich 2007 Abstract O141
29. P.M. Flynn, N. Seibel, A. Arrieta, D. Facklam, L. Kovanda, and W. Lau Treatment of invasive aspergillosis (IA) in pediatric patients (Pts) with micafungin (MICA) alone or in combination with other systemic antifungal agents 46th Interscience Conference for Antimicrobial Agents and Chemotherapy (ICAAC) S. Francisco 2006 Abstract M-891.
30. A. Arrieta, P. Maddison, and A.H. Groll Micafungin in pediatric patients: assessment of safety in clinical trials Interscience Conference for Antimicrobial Agents and Chemotherapy (ICAAC) Chicago 2007 Abstract M-1182
31. P.G. Pappas, C.M. Rotstein, R.F. Betts, M. Nucci, D. Talwar, and J.J. De Waele Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis Clin Infect Dis 45 2007 883 893 (Pubitemid 47580382)
32. A. Gafter-Gvili, L. Vidal, E. Goldberg, L. Leibovici, and M. Paul Treatment of invasive candidal infections: systematic review and meta-analysis Mayo Clin Proc 83 2008 1011 1021
33. European Medicines Agency Assessment report for mycamine (EMEA/H/C/000734) [consultado 29-9-2010]. Disponible en: http//www.emea.europa. eu/humandocs/PDFs/EPAR/mycamine/H-734-en6.pdf